期刊文献+

易损斑块研究进展 被引量:5

Developments of vulnerable plaque
暂未订购
导出
摘要 自1844年学者们首次对动脉粥样硬化破裂斑块的组织学进行描述以来,一些领先的研究者和临床医师进行了大量研究,使当今不稳定的斑块导致斑块破裂的观点得到普遍接受.
作者 顾菲菲
出处 《中国心血管病研究》 CAS 2012年第1期63-65,共3页 Chinese Journal of Cardiovascular Research
  • 相关文献

参考文献19

  • 1Finn AV, Nakano M, Narula J, et al. Concept of vulnerable/unstable plaque. Artefiosoler Throrab Vasc Biol,2010,30:1282-1292.
  • 2Maintz D. Plaque and differentiation benhanced inversion clinical research. Copyright Oxford Univ, 2006,27 : 1732-1736.
  • 3Fishbein MC. The vulnerable and unstable athemsclerotic plaque. C ardiovasc Pathol, 2010,19 : 6-11.
  • 4Moreno PR. Vulnerable plaque: definition, diagnosis, and treatment. Cardiol Clin,2010,28:1-30.
  • 5Kips JG, Segers P, Van Bortel LM. Identifying the vulnerable plaque: A review of invasive and non-invasive imaging modalities. Artery Research,2008,2:21-34.
  • 6Ambrose JA, Srikanth S. Vulnerable plaques and patients: improving prediction of future coronary events. Am J Med, 2010,123 : 10-16.
  • 7Hellings WE, Peeters W, Moll FL, et al. From vulnerable plaque to vulnerable patient: the search for biomarkers of plaque destabilization. Trends Cardiovasc Med,2007,17:162-171.
  • 8Virmani R, Burke AP, Farb A, et al. Pathology of the vulnerable plaque. J Am Coil Cardiol, 2006,47 : C 13-18.
  • 9Valgimigli M, Agostonl P, Serruvs PW. Acute coronary syndromes: an emphasis shift from treatment to prevention; and the enduring challenge of vulnerable plaque detection in the cardiac catheterization laboratory. J Cardiovasc Med (Hagerstown), 2007,8 : 221-229.
  • 10Friedewald VE, Ambrose JA, Stone GW, et al. The editor's roundtable: the vulnerable plaque. Am J Cardiol,2008,102: 1644-1653.

二级参考文献20

  • 1倪祝华,杨新春,王乐丰,邹阳春,王红石,葛永贵,佟子川.中等程度冠状动脉狭窄的血管内超声特点与治疗决策选择[J].中国介入影像与治疗学,2005,2(1):15-18. 被引量:16
  • 2李卫华,滕志涛,吴荣,谢强,郭启军,唐蓉,陈焕章.血管内超声诊断冠脉造影阴性不稳定斑块5例分析[J].中国心血管病研究,2005,3(7):497-498. 被引量:5
  • 3程训民,何国祥,仝识非,冉擘力,刘建平,姚青,宋治远.血管内超声显像指标对冠状动脉中度狭窄病变功能意义的判断价值[J].心肺血管病杂志,2005,24(3):132-135. 被引量:15
  • 4Kawasaki M,Sano K,Okubo M,et al.Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound.J Am Coll Cardiol,2005,45:1946-1953.
  • 5Roy P,Steinberg DH,Sushinsky SJ,et al.The potential clinical utility of intravas -cular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents.Eur Heart J,2008,29:1851-1857.
  • 6Park SJ,Kim YH,Park DW,et al.Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis.Circ Cardiovasc Interv,2009,2:167-177.
  • 7Aoki J,Nakazawa G,Tanabe K,et al.Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation.Catheter Cardiovasc Interv,2007,69:380-386.
  • 8Nicholls SJ,Tuzcu EM,Wolski K,et al.Coronary artery calcification and changes in atheroma burden in response to established medical therapies.J Am Coll Cardiol,2007,49:263-270.
  • 9Yasue H,Nakagawa H,Itoh T,et al.Coronary artery spasm-clinical features,diagnosis,pathogenesis,and treatment.J Cardiol,2008,51:2-17.
  • 10Stern S,Bayes de Luna A.Coronary artery spasm:a 2009 update.Circulation,2009,119:2531-2534.

共引文献10

同被引文献62

  • 1Toth PP, Mccullough PA ,Wegner MS, et al. Lipoprotein-associ- ated phospholipase A2: role in arteriosclerosis and utility as a cardiovascular biomarker.Expert Rev Cardiovasc Ther,2010,8: 425-438.
  • 2Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol,1983,51:606- 612.
  • 3Chen YL , Bhasin A , Youssef AA, et al. Prognostic factors and outcomes in young chinese patients with acute myocardial infarc- tion undergoing primary coronary angioplasty. Int Heart J, 2009, 50:1-11.
  • 4Knoflaeh M,Kiechl S,Penz D, et al. Cardiovascular risk factors and atherosclerosis in young women: athemsclerosis risk factors in female youngsters. Stroke, 2009,40:1063-1069.
  • 5Chua SK, Hung HF, Shyu KG, et al. Acute ST-elevation myocar- dial infarction in young patients: 15 years of experience in a sin- gle center.Clin Cardiol, 2010,33:140-148.
  • 6Vickers KC, Magui.re CT, Wolfert R, et al. Relationship of lipoprotein-assoeiated Phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis. J Lipid Res, 2009, 50: 1735-1743.
  • 7Jinbo L,Rui C,Gopal K, et al. Circulating plateletactivating factor is primarily cleared by transport,not intravascular hy- drolysis by lipoprotein -associated phospholipase A2/PAF acetylhydrolase. Circ Res, 2011,108: 469-477.
  • 8Erqou S, Kaptoge S, Perry PL, et al.Lipoprotein (a) concen- tration and the risk of coronary heart disease,stroke, and nonvascular mortality. JAMA,2009,302: 412-423.
  • 9Tsimikas S,Mallat Z,Talmud PJ, et al.Oxidation-specific biomarkers,lipoprotein (a),and risk of fatal and nonfatal coro- nary events.Am Coil Cardiol, 2010, 56: 946-955.
  • 10Packard CJ. Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target. Curr Opin Cardio1,2009,24: 358-363.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部